We are live on ! Find out more
MC

Merck & Co Portfolio holdings

AUM $349M
1-Year Est. Return 146.07%
This Fund
S&P 500
This Quarter Est. Return
-35.67%
1 Year Est. Return
+146.07%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$164M
AUM Growth
-$93.8M
Cap. Flow
+$439K
Cap. Flow %
0.27%
Top 10 Hldgs %
99.69%
Holding
13
New
–
Increased
1
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
EVAX
Evaxion A/S
EVAX
+$3.05M

Top Sells

Rank Stock Value
1
ABSI icon
Absci
ABSI
+$2.62M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRNA icon
1
Moderna
MRNA
$21.5B
$65.4M 39.83%
2,308,190
– –
PSNL icon
2
Personalis
PSNL
$1.39B
$49.3M 30.01%
14,044,943
– –
KYMR icon
3
Kymera Therapeutics
KYMR
$8.75B
$21.1M 12.86%
772,165
– –
TRDA icon
4
Entrada Therapeutics
TRDA
$267M
$15.7M 9.57%
1,739,768
– –
ALEC icon
5
Alector
ALEC
$203M
$4.36M 2.65%
3,545,719
– –
EVAX
6
Evaxion A/S
EVAX
$25M
$2.25M 1.37%
1,214,126
+1,105,670
+1,019% +$3.05M
STRO icon
7
Sutro Biopharma
STRO
$400M
$1.77M 1.08%
272,351
– –
LVTX
8
DELISTED
LAVA Therapeutics
LVTX
$1.46M 0.89%
1,149,345
– –
VRDN icon
9
Viridian Therapeutics
VRDN
$2.49B
$1.26M 0.77%
93,414
– –
XLO icon
10
Xilio Therapeutics
XLO
$61M
$1.07M 0.65%
105,983
– –
CARM
11
DELISTED
Carisma Therapeutics
CARM
$457K 0.28%
1,473,240
– –
NEUP
12
Neuphoria Therapeutics
NEUP
$21.1M
$57.8K 0.04%
10,027
– –
ABSI icon
13
Absci
ABSI
$1.41B
– –
-998,163
Closed -$2.62M

Similar funds

KFG
Kingdom Financial Group Peoria, Arizona $349M AUM 12.25% 1-Year Est. Return
LAS
Lloyd Advisory Services Suwanee, Georgia $349M AUM 13.97% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
EPW
Endeavor Private Wealth Topeka, Kansas $349M AUM 16.45% 1-Year Est. Return
NC
Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return
1CP
11 Capital Partners Darien, Connecticut $348M AUM 19.84% 1-Year Est. Return
SMC
Spider Management Company Richmond, Virginia $351M AUM 18.35% 1-Year Est. Return
AWA
Argos Wealth Advisors Sacramento, California $348M AUM

Merck & Co's Q1 2025 Portfolio in Review

As of Q1 2025, Merck & Co held 13 positions worth $164M, down 36% from $258M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Merck & Co's Q1 2025 filing shows 1 increased and 1 closed positions. The largest sale was Absci, an estimated $2.62M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Merck & Co added most to Evaxion A/S in Q1 2025, an estimated $3.05M increase.
  • Merck & Co fully exited Absci in Q1 2025, selling an estimated $2.62M.
  • Merck & Co's ten largest holdings make up 100% of its $164M portfolio in Q1 2025.
  • Merck & Co opened 0 new positions and closed 1 in Q1 2025.
  • Merck & Co's portfolio value fell 36% quarter-over-quarter to $164M.

Based on Merck & Co's 13F filing for Q1 2025, filed 14 May 2025.